Answer
Yes, hepatitis B reactivation causing hepatitis, sometimes fatal, has been reported with temozolomide; liver disease experts should be consulted before treatment in patients with positive hepatitis B serology, including active disease, and patients should be monitored and managed appropriately during treatment.
Sources for this answer
- Temodal CapsulesMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 37Document updated
Sources checked